Apart from cardiovascular diseases, deficiency of PARP1 can also alleviate pulmonary fibrosis (Zhang et al., 2018), while PARP1 overactivation can lead to hepatic fibrosis (Mukhopadhyay et al., 2014). This evidence concerns the gene PARP1 and cardiovascular disorder.